Moonlight Therapeutics

Moonlight is developing a microneedle-based immunotherapy for peanut allergy. Its proprietary platform delivers a controlled dose of peanut antigens through the skin to induce immune tolerance. The company has secured a method of treatment patent and is advancing its lead program into Phase I clinical trials.